Greif (GEF) insider files to sell 14,465 shares worth $1.04M

Rhea-AI Filing Summary

Greif, Inc. insider plans a Rule 144 stock sale. A holder has filed to sell 14,465 shares of Greif common stock through Morgan Stanley Smith Barney, with an aggregate market value of $1,040,523.86, on or about February 3, 2026, on the NYSE.

The shares were originally acquired as performance stock units from the issuer in January 2019 and February 2020 as compensation for services. The notice also shows that Lawrence A. Hilsheimer sold 4,500 common shares for $273,240 on November 17, 2025. Shares outstanding are 24,751,957.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14465	1040523.86	24751957	02/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/18/2019	Performance Stock Units	Issuer			6317	01/18/2019	Services Rendered
Common	02/28/2020	Performance Stock Units	Issuer			8148	02/28/2020	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
LAWRENCE A HILSHEIMER 425 Winter Road Delaware OH 43015	Common	11/17/2025	4500	273240.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for GEF disclose?

The Form 144 filing discloses a planned sale of 14,465 Greif (GEF) common shares. The shares are to be sold through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $1,040,523.86 and a stated approximate sale date of February 3, 2026.

How many Greif (GEF) shares is the insider planning to sell and at what value?

The insider plans to sell 14,465 Greif common shares with an aggregate market value of $1,040,523.86. This planned transaction is to be executed through Morgan Stanley Smith Barney on the NYSE, according to the Rule 144 notice for an approximate sale date of February 3, 2026.

How were the Greif (GEF) shares in this Form 144 originally acquired?

The Greif shares were acquired through performance stock units granted by the issuer. Awards dated January 18, 2019 and February 28, 2020 provided 6,317 and 8,148 common shares, respectively, as compensation for services rendered, which now underpin the planned Rule 144 stock sale.

What recent Greif (GEF) stock sales by the filer are disclosed?

The filing shows that Lawrence A. Hilsheimer sold 4,500 Greif common shares on November 17, 2025. Those shares generated gross proceeds of $273,240. This transaction occurred within the three months prior to the new planned 14,465-share sale reported in the current notice.

How many Greif (GEF) shares are outstanding in this Form 144 notice?

The notice reports 24,751,957 Greif common shares outstanding. This figure provides context for the planned sale of 14,465 shares under Rule 144, helping readers see the planned transaction relative to the total number of common shares currently outstanding.

Which broker will handle the Greif (GEF) Rule 144 stock sale?

The planned Greif stock sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed office is at 1 New York Plaza, 8th Floor, New York, NY 10004, and the transaction is designated for execution on the NYSE.